You got no response from the mjf institute is because low dose naltrexone has been kicking around for awhile and it wouldn't stem from an "original idea" or be considered so by one of the bloats at the head of research. These people only have their own or their cohorts interests to serve. To hell with anybody else who would dare "scale the walls" of their ivory tower ramparts.